Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Janna Afanasjeva"'
Autor:
Kyle Strnad, Kathryn M. Momary, Monica Fahmy, Anne M. Williams, Brittany Florczykowski, Brooke A. Smith, Emma M. Tillman, Craig J. Beavers, Aparna Yerramilli, Janna Afanasjeva
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:754-764
Publikováno v:
Hosp Pharm
This is an update to the 2010 article published in Hospital Pharmacy on safety concerns involving transdermal patches and magnetic resonance imaging (MRI). Since publication of the original article, new brand and generic transdermal medications have
Autor:
Maria Sheridan, Jimmi Hatton Kolpek, Jason H. Karnes, Kara L. Birrer, Christine M. Formea, Rebecca Pulk, Jonathan G. Leung, Janna Afanasjeva, Molly G. Minze, Elias B. Chahine, Chasity M. Shelton, Lamis R. Karaoui, Christopher R. Ensor, Eglis Tellez-Corrales, Christine M. Walko, James C. Lee, Angela Q. Maldonado, Keri C. Anderson, Erin F. Barreto, Jomy M. George, Roseann S. Gammal, Shubha Bhat, Craig J. Beavers, Stephanie A. Flowers, Mary F. Hebert, Kelly E. Caudle, Michael A. Smith, Scott A Soefje, Larisa H. Cavallari, Rena A. Gosser
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2:288-302
Autor:
John Fanikos, Ryan Rodriguez, Patricia Masters, Genevieve Jeni Hayes, Mark Sinnett, Janna Afanasjeva, Francesca Fran Cunningham, Michael Gabay, Muriel Burk
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 78(2)
Autor:
Rita L. Hui, Jennifer T Chang, Janna Afanasjeva, Mirta Millares, Nazia Rashid, Michele M. Spence, Joanne E. Schottinger
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36:1065-1074
tudy Objectives To identify subsequent therapies used after first-line therapies in patients with advanced non–small cell lung cancer (NSCLC), compare overall survival (OS) associated with subsequent therapies, and evaluate factors associated with
Autor:
Janna Afanasjeva
Publikováno v:
Hospital pharmacy. 52(9)
Background: Vitamin K, or phytonadione, is available in both injectable and oral formulations. Oral vitamin K is available as 5-mg tablets, but the key drawbacks for using vitamin K tablets consist of availability of only 1 dose strength and recent t
Autor:
Katherine Gruenberg, Janna Afanasjeva
Publikováno v:
Sustainable Chemistry and Pharmacy. 13:100164
As the awareness about the negative effects of disposed medications on the environment increases, pharmacists and pharmacy administrators must be aware of potential waste minimization strategies to implement in community and hospital pharmacies. Educ